This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Oscar Krijgsman group

Krijgsman, Oscar.JPG

Oscar Krijgsman

Postdoctoral fellow

Personal details


After internships at the DKFZ (Heidelberg, Germany) and the VUmc (Amsterdam) I completed my Masters in Bioinformatics at the VU university in Amsterdam. Following my masters I worked as a bioinformatician in R&D at the NKI spinoff Agendia (Amsterdam). In 2009 I started my PhD in the group of Bauke Ylstra and defended my PhD thesis in March 2015.

In September 2013 I joined the Peeper group, where I study drug-resistance and combination therapies for personalized medicine in cancer. In the last years the focus of the lab and my research shifted from resistance to targeted therapies to resistance and prediction of responds to Immune-checkpoint blockade, the current first line treatment for melanoma and lung cancer.

Share this page